← Signals · Financials · TSXV
$LBI
Lions Bay Capital Inc.
Signal as of N/A  ·  90-day rolling window  ·  Asset Management Services
Confluence Score
out of 100  ·  Full breakdown →
Score delayed 7 days on Free  ·  See today's score — Analyst →
Signals scoring 20–39 have historically hit 47% of the time (avg +6.8% over 90 days, 105 backtested signals). Methodology →
🔒 Risk monitoring — insider-selling & reversal warnings (Analyst)
Confluence Score
Insider Activity (90d)
11
1 buyer  ·  $36K  ·  open-market only
Current Price
$0.32
CAD  ·  5-min cache
Market Cap
$13M
CAD  ·  TMX
Lobbying & Contracts
None
0 regs  ·  0 contracts
Financials on Form55: 81% hit rate · +8.2% alpha vs XIU.TO · 52 closed signals Track Record →
Signal Analyst
The Confluence Score and insider trade feed above are free. Signal Analyst adds the full component breakdown, lobbying registrations, and contract wins — plus alerts when this company's signal moves, so you don't have to keep checking back.
Monitor — CAD $29/mo
Price Chart
12 months daily  ·  TSXV:LBI
Insider Transactions
90-day window  ·  11 filings
Date Insider Role Nature Dir. Shares Buy Price Return Value
Jun 04, 2026 Byrne, John Joseph Open Market Buy 2,000 $0.23 +39.1%  · 37d $460
Jun 04, 2026 Byrne, John Joseph Open Market Buy 1,000 $0.24 +33.3%  · 37d $240
Jun 04, 2026 Byrne, John Joseph Open Market Buy 2,000 $0.24 +33.3%  · 37d $480
May 13, 2026 Byrne, John Joseph Open Market Buy 4,000 $0.29 +10.3%  · 59d $1K
Apr 28, 2026 Byrne, John Joseph Open Market Buy 17,500 $0.24 +33.3%  · 74d $4K
Apr 28, 2026 Byrne, John Joseph Open Market Buy 2,500 $0.24 +30.6%  · 74d $612
Apr 27, 2026 Byrne, John Joseph Open Market Buy 25,000 $0.24 +33.3%  · 75d $6K
Apr 27, 2026 Byrne, John Joseph Open Market Buy 25,000 $0.24 +33.3%  · 75d $6K
Apr 27, 2026 Byrne, John Joseph Open Market Buy 26,500 $0.24 +33.3%  · 75d $6K
Apr 24, 2026 Byrne, John Joseph Open Market Buy 43,000 $0.22 +45.5%  · 78d $9K
Apr 24, 2026 Byrne, John Joseph Open Market Buy 5,500 $0.21 +48.8%  · 78d $1K
Score uses open-market buys only  ·  11 open-market  ·  Return is unrealized, to today's price; a “· Nd” mark means the 90-day window is still open (N of 90 days) — too early to judge.
Score Breakdown
Signal Analyst  ·  $29/mo
Component Points Max Detail Weight
Conviction (unique buyers)  ✓ FREE PREVIEW 30 30 1 unique buyer (maximum conviction)
Buy/sell ratio 20 100% buys (11B / 0S)
Dollar value 25 $36K
Lobbying activity 15 None
Contract wins 10 None
Insider track record 10 No track record data
Private placements 8 None
Confluence bonus 10 None
Cluster timing (velocity) 10 No coordinated buying cluster detected
Buy/sell reversal pattern 8 No buy/sell reversal pattern
Total 0 100
Unlock Component Detail — CAD $29/mo
Buying Insiders
Open-market · 90 days · 1 unique buyer
Insider Credibility Hit Rate Avg 90d Return Trades (eval'd) Buy Value (90d) Last Buy
Byrne, John Joseph $36K Jun 04, 2026
Credibility score: historical hit rate × avg 90d return × sample size. View full insider leaderboard →
Lobbying Registrations
OCL active  ·  none found
No active OCL lobbying registrations in the last 90 days. Analyst plan →
Government Contract Wins
90-day window  ·  none found
No government contract wins in the last 90 days. Analyst plan →
Private Placements
12 months  ·  Signal Analyst  ·  $29/mo
Private placement history, deal size, and lock-up expiry tracking. Analyst plan →
Indigenous Consultation
no records on file

No Indigenous consultation records on file for LBI.

SEDAR+ Filings
official filing registry
Form55 monitors SEDAR+ filing alerts and newswire announcements for Technical Reports and material changes. Search SEDAR+ →
Boardroom Connections
2 insiders also active elsewhere
Insider Other boards Also an insider at
Balic, Anthony Bob 3 GRB (55), FMN, GGA
Byrne, John Joseph 1 FMN
People who file as insiders here and at other TSX/TSXV companies (number in brackets = that company's Confluence Score). A well-connected insider taking a seat at a new junior can be an early tell. Matched by name across SEDI filings; funds and 10%+ holders excluded.
Form55 provides data and analysis for informational purposes only. Nothing on this site constitutes investment advice or a recommendation to buy or sell any security. Past performance is not indicative of future results.